|
|
|
| Webinar: AAV Analytics: Key Considerations When Developing a Clinical Program | Challenges like inadequate analytical development can stall an advanced therapy's development. At Andelyn, method validation has been integral to our processes. We develop assays from our research to meet the standards of large-scale GMP production of plasmids and viral vectors. Please join Andelyn to learn key considerations for taking your AAV gene therapy from concept to commercialization with advanced analytics. Click here to learn more. |
|
|
|
|
By Pankaj Singh, Global Market Insights | You can't improve what you don't measure. This discussion explores advances in cell counting technology and the growing number of ways it aids the biotech industry and beyond. |
|
|
|
In this segment, our expert panelists cover the variability drivers for allogeneic cell therapies, the criteria or non-negotiables for a healthy donor, as well as the biggest challenges in batch-to-batch variation for allogeneic cell therapy manufacturing. |
|
|
|
|
|
| Scalable Plasmid, mRNA Manufacturing Process Development | Article | By Yong Wu, Zihou Fang, Yijun Shen, Houliang Wei, Qinrgrui You, Guodong Jia, and Weiran Shen, OBiO Tech | Review a successful optimization process that increases the yield of plasmids, the precursors for mRNA synthesis, and achieves a scalable, efficient process for high-quality mRNA production. |
|
|
| Optimizing Plasmid Production Strategies And Partnerships | Article | By Erika Morris, Ajinomoto Bio-Pharma Services | To find the plasmid manufacturer with the appropriate knowledge and experience to manufacture your plasmid with quality and efficiency, you’ll need to recognize the offerings of a seasoned supplier. |
|
|
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|
